| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2b0ede063942517e95f4fd0482963f1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-529
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502 |
| filingDate |
2006-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_832793adb8c280ff2aa9a789289c3967 |
| publicationDate |
2011-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2429848-C2 |
| titleOfInvention |
Compositions for treating systemic mastocytosis |
| abstract |
FIELD: medicine. ^ SUBSTANCE: application involves a combination of AMN107 and PKC412 tyrosine kinase inhibitors for preparing a therapeutic agent for treating systemic mastocytosis (SM), including associated with oncogenic mutation KIT-D816V. The use of the invention enables higher clinical effectiveness of treating SM due to synergetic mast cell growth inhibition under action of the AMN107 and PKC412 combination. ^ EFFECT: higher efficacy of the composition. ^ 3 cl, 3 tbl, 17 dwg, 2 ex |
| priorityDate |
2005-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |